These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30862650)

  • 1. Nonadherence to Insulin Therapy Detected by Bluetooth-Enabled Pen Cap Is Associated With Poor Glycemic Control.
    Munshi MN; Slyne C; Greenberg JM; Greaves T; Lee A; Carl S; Atakov-Castillo A; Toschi E
    Diabetes Care; 2019 Jun; 42(6):1129-1131. PubMed ID: 30862650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Relationship Between Pre- and Postprandial Glucose Levels and Insulin Bolus Timing Using Bluetooth-Enabled Insulin Pen Cap Technology and Continuous Glucose Monitoring.
    Toschi E; Slyne C; Greenberg JM; Greaves T; Atakov-Castillo A; Carl S; Dufour AB; Munshi M
    Diabetes Technol Ther; 2020 Jan; 22(1):19-24. PubMed ID: 31483167
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
    Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
    Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
    Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
    Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
    Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
    Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
    Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
    Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.
    Galasso S; Facchinetti A; Bonora BM; Mariano V; Boscari F; Cipponeri E; Maran A; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1112-1119. PubMed ID: 27618501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes.
    Feldman BS; Cohen-Stavi CJ; Leibowitz M; Hoshen MB; Singer SR; Bitterman H; Lieberman N; Balicer RD
    PLoS One; 2014; 9(9):e108145. PubMed ID: 25259843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.
    Pohlmeier H; Berard L; Brulle-Wohlhueter C; Wu J; Dahmen R; Nowotny I; Klonoff D
    J Diabetes Sci Technol; 2017 Mar; 11(2):263-269. PubMed ID: 27664062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of insulin glargine vial use beyond 28 days in a Medicaid population.
    Turner JM; Unni EJ; Strohecker J; Henrichs J
    J Am Pharm Assoc (2003); 2018; 58(4S):S37-S40. PubMed ID: 29801995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 14. Aids for insulin users.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):70-5. PubMed ID: 25868300
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin pens.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):68-9. PubMed ID: 25868299
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of medication adherence in diabetes mellitus patients on human versus analogue insulins.
    Machado-Alba JE; Medina-Morales DA; Echeverri-Cataño LF
    Expert Opin Drug Saf; 2017 Feb; 16(2):133-137. PubMed ID: 28002970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice.
    Bailey TS; Stone JY
    Expert Opin Drug Deliv; 2017 May; 14(5):697-703. PubMed ID: 28359171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.